Zn(II) metal-based antitumor drug entities were synthesized from substituted benzothiazole o‒vanillin Schiff base ligands. The complexes were thoroughly characterized by elemental analysis, spectroscopic studies IR, 1H & 13C NMR, ESI−MS, EPR} and magnetic susceptibility measurements. The structure activity relationship (SAR) studies of benzothiazole Cu(II) & Zn(II) complexes having molecular formulas [C30H22CuN5O7S2]
新定制的Cu(II)的Zn(II)
金属系
抗肿瘤药物的实体被选自取代的
苯并噻唑合成ö -vanillin席夫碱
配体。通过元素分析,光谱研究IR,1 H和13 C NMR,ESI-MS,EPR}和磁化率测量对复合物进行了全面表征。具有分子式[C 30 H 22 CuN 5 O 7 S 2 ],[C 30 H 20 Cl 2 CuN 5 O 7 S 2 ]的
苯并噻唑Cu(II)和Zn(II)配合物的结构活性关系(
SAR)研究,[C 30H 20 CuF 2 N 5 O 7 S 2 ],[C 30 H 22 N 4 O 4 S 2 Zn],[C 30 H 20 Cl 2 N 4 O 4 S 2 Zn]和[C 30 H 20 F 2通过吸收,发射滴定和流体力学测量,用CT‒DNA进行N 5 O 7 S 2 Zn]的测定。DNA结合亲和力通过K b和K sv值对
氯取代的Cu(II)[C 30 H 20